Yang, Yiqing; Tang, Tongke; Li, Xiaolu; Michel, Thomas; Ling, Liqin; Huang, Zhenghui; Mulaka, Maruthi; Wu, Yue; Gao, Hongying; Wang, Liguo; Zhou, Jing; Meunier, Brigitte; Ke, Hangjun; Jiang, Lubin; Rao, Yu published the artcile< Design, synthesis, and biological evaluation of multiple targeting antimalarials>, Application In Synthesis of 103261-68-3, the main research area is quinoline preparation antimalarial; Antimalarial inhibitors; Drug design; Mechanism of action; Membrane proteins; Multiple targeting compounds.
Here, authors performed a structure-based drug design on mitochondrial respiratory chain of Plasmodium falciparum and identified an extremely potent mol., RYL-581, which binds to multiple protein binding sites of P. falciparum simultaneously (allosteric site of type II NADH dehydrogenase, Qo and Qi sites of cytochrome bc1). Antimalarials with such multiple targeting mechanism of action have never been reported before. RYL-581 kills various drug-resistant strains in vitro and shows good solubility as well as in vivo activity. This structure-based strategy for designing RYL-581 from starting compound may be helpful for other medicinal chem. projects in the future, especially for drug discovery on membrane-associated targets.
Acta Pharmaceutica Sinica B published new progress about Antimalarials. 103261-68-3 belongs to class nitriles-buliding-blocks, and the molecular formula is C10H9NO2, Application In Synthesis of 103261-68-3.
Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts